Ultragenyx Pharmaceutical Total Current Liabilities 2012-2024 | RARE
Ultragenyx Pharmaceutical total current liabilities for the quarter ending June 30, 2024 were $0.273B, a 11.66% increase year-over-year.
- Ultragenyx Pharmaceutical total current liabilities for 2023 were $0.28B, a 7.36% increase from 2022.
- Ultragenyx Pharmaceutical total current liabilities for 2022 were $0.261B, a 44.02% increase from 2021.
- Ultragenyx Pharmaceutical total current liabilities for 2021 were $0.181B, a 4.35% decline from 2020.